Mild cognitive impairment in the era of biological therapy: the importance of early intervention
Neurologie pro praxi · 02.10.2026 · 27 (4) · 291-294
DOI: 10.36290/neu.2026.049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurologie pro praxi, erschienen am 02.10.2026. Verfasst von Jiří Cerman und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Mrn kognitivn porucha (MCI) pedstavuje heterogenn klinick syndrom, kter se v souasnosti dostv do centra pozornosti dky nstupu nov biologick lby Alzheimerovy nemoci. Pestoe tyto terapie otevraj nov monosti kauzln intervence, jejich vyuit v reln praxi zstv omezeno na pomrn zkou skupinu pacient, pro kter je tato lba vhodn. lnek shrnuje souasn monosti managementu MCI v bn klinick praxi a zamuje se pedevm na racionln pstupy k asn intervenci u pacient, kte nejsou kandidty biologick lby.
Zitieren
APA
Cerman, J., Knápková, K., & Hort, J. (2026). Mild cognitive impairment in the era of biological therapy: the importance of early intervention. Neurologie pro praxi, 27(4), 291-294. https://doi.org/10.36290/neu.2026.049
Vancouver
Cerman J, Knápková K, Hort J. Mild cognitive impairment in the era of biological therapy: the importance of early intervention. Neurologie pro praxi. 2026;27(4):291-294. doi:10.36290/neu.2026.049
BibTeX
@article{Cerman2026,
author = {Cerman, Jiří and Knápková, Klára and Hort, Jakub},
title = {Mild cognitive impairment in the era of biological therapy: the importance of early intervention},
journal = {Neurologie pro praxi},
year = {2026},
volume = {27},
number = {4},
pages = {291--294},
doi = {10.36290/neu.2026.049}
}
EUVIMED